BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8916076)

  • 1. Vesicular monoamine transporter 2 expression in enteric neurons and enterochromaffin-like cells of the rat.
    De Giorgio R; Su D; Peter D; Edwards RH; Brecha NC; Sternini C
    Neurosci Lett; 1996 Oct; 217(2-3):77-80. PubMed ID: 8916076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vesicular amine transporter expression and isoform selection in developing brain, peripheral nervous system and gut.
    Schütz B; Schäfer MK; Eiden LE; Weihe E
    Brain Res Dev Brain Res; 1998 Mar; 106(1-2):181-204. PubMed ID: 9555003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-alpha directly augments histidine decarboxylase and vesicular monoamine transporter 2 production in rat enterochromaffin-like cells.
    Kazumori H; Ishihara S; Rumi MA; Ortega-Cava CF; Kadowaki Y; Kinoshita Y
    Am J Physiol Gastrointest Liver Physiol; 2004 Mar; 286(3):G508-14. PubMed ID: 14563668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of two vesicular monoamine transporters.
    Peter D; Liu Y; Sternini C; de Giorgio R; Brecha N; Edwards RH
    J Neurosci; 1995 Sep; 15(9):6179-88. PubMed ID: 7666200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat.
    Weihe E; Schäfer MK; Erickson JD; Eiden LE
    J Mol Neurosci; 1994; 5(3):149-64. PubMed ID: 7654518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesicular monoamine transporter 2 as a marker of gastric enterochromaffin-like cell tumors.
    Rindi G; Paolotti D; Fiocca R; Wiedenmann B; Henry JP; Solcia E
    Virchows Arch; 2000 Mar; 436(3):217-23. PubMed ID: 10782879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vesicular monoamine transporters in the rat stomach.
    Hunyady B; Palkovits M; Mezey E
    J Physiol Paris; 2000; 94(2):123-30. PubMed ID: 10791693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the two isoforms of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumors.
    Anlauf M; Eissele R; Schäfer MK; Eiden LE; Arnold R; Pauser U; Klöppel G; Weihe E
    J Histochem Cytochem; 2003 Aug; 51(8):1027-40. PubMed ID: 12871984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei.
    Nirenberg MJ; Liu Y; Peter D; Edwards RH; Pickel VM
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8773-7. PubMed ID: 7568015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogeny of vesicular monoamine transporter mRNAs VMAT1 and VMAT2. II. Expression in neural crest derivatives and their target sites in the rat.
    Hansson SR; Mezey E; Hoffman BJ
    Brain Res Dev Brain Res; 1998 Sep; 110(1):159-74. PubMed ID: 9733958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ontogeny of vesicular monoamine transporter mRNAs VMAT1 and VMAT2. I. The developing rat central nervous system.
    Hansson SR; Hoffman BJ; Mezey E
    Brain Res Dev Brain Res; 1998 Sep; 110(1):135-58. PubMed ID: 9733951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter.
    Erickson JD; Schafer MK; Bonner TI; Eiden LE; Weihe E
    Proc Natl Acad Sci U S A; 1996 May; 93(10):5166-71. PubMed ID: 8643547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of gastrin processing by vesicular monoamine transporter type 1 (VMAT1) in rat gastrin cells.
    Hussain I; Bate GW; Henry J; Djali P; Dimaline R; Dockray GJ; Varro A
    J Physiol; 1999 Jun; 517 ( Pt 2)(Pt 2):495-505. PubMed ID: 10332097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrin induces expression and promoter activity of the vesicular monoamine transporter subtype 2.
    Gerhard M; Neumayer N; Presecan-Siedel E; Zanner R; Lengyel E; Cramer T; Höcker M; Prinz C
    Endocrinology; 2001 Aug; 142(8):3663-72. PubMed ID: 11459816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Region-specific targeting of dopamine D2-receptors and somatodendritic vesicular monoamine transporter 2 (VMAT2) within ventral tegmental area subdivisions.
    Pickel VM; Chan J; Nirenberg MJ
    Synapse; 2002 Aug; 45(2):113-24. PubMed ID: 12112404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of dopamine transporter and vesicular monoamine transporter 2 mRNAs in rat midbrain after repeated amphetamine administration.
    Lu W; Wolf ME
    Brain Res Mol Brain Res; 1997 Oct; 49(1-2):137-48. PubMed ID: 9387873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exocytotic proteins in enterochromaffin-like (ECL) cells of the rat stomach.
    Zhao CM; Jacobsson G; Chen D; Hâkanson R; Meister B
    Cell Tissue Res; 1997 Dec; 290(3):539-51. PubMed ID: 9369530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient expression of the vesicular monoamine transporter during development in the rat thalamus and cortex.
    Leroux-Nicollet I; Costentin J
    Neurosci Lett; 1998 Jun; 248(3):167-70. PubMed ID: 9654335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata.
    Staal RG; Sonsalla PK
    J Pharmacol Exp Ther; 2000 May; 293(2):336-42. PubMed ID: 10773000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vesicular monoamine transporter-2: immunogold localization in striatal axons and terminals.
    Nirenberg MJ; Chan J; Liu Y; Edwards RH; Pickel VM
    Synapse; 1997 Jun; 26(2):194-8. PubMed ID: 9131778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.